Evidence map›Paper›PMID 37089720›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2023

Correlation of Serum FGF23 and Chronic Kidney Disease-Mineral and Bone Abnormality Markers With Cardiac Structure Changes in Maintenance Hemodialysis Patients.

Dewang Zeng, Aiyun Zha, Ying Lei, Zongchao Yu, Rui Cao, Ling Li, Zhuoheng Song, Weilong Li, Yunyi Li, Haiping Liu and 12 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 2 countries.

Dewang ZengDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.ORCID https://orcid.org/0000-0001-5754-5843
Aiyun ZhaDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Ying LeiDepartment of Nephrology, Huadu District People's Hospital, Guangzhou, China.ORCID https://orcid.org/0000-0002-0505-8987
Zongchao YuDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Rui CaoDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Ling LiHospital of South China Agricultural University, Guangzhou 510642, China.
Zhuoheng SongDepartment of Nephrology, Shenzhen Longhua District Central Hospital, Guangdong, Shenzhen 518110, China.
Weilong LiDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Yunyi LiDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Haiping LiuThe Second People's Hospital of Lianping County, Heyuan, Guangdong 517139, China.
Shaoxing HuangThe Second People's Hospital of Lianping County, Heyuan, Guangdong 517139, China.
Xiangnan DongDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Bernhard KrämerFifth Department of Medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Berthold HocherFifth Department of Medicine, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Lianghong YinDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.ORCID https://orcid.org/0000-0002-5005-5304
Chen YunDepartment of Nephrology, Charité -Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
Stanislao MorgeraDepartment of Nephrology, Charité -Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.
Baozhang GuanDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Yu MengDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Fanna LiuDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.
Bo HuDepartment of Nephrology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China.ORCID https://orcid.org/0000-0001-6944-3449
Shaodong LuanDepartment of Nephrology, Shenzhen Longhua District Central Hospital, Guangdong, Shenzhen 518110, China.
First Affiliated Hospital of Jinan University · CNLonggang Central Hospital · CNCharité - Universitätsmedizin Berlin · DEHeidelberg University · DEXian Yang Central Hospital · CNSouth China Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: CKD-MBD is a mineral and bone metabolism syndrome caused by chronic kidney disease. FGF23 is an important factor regulating phosphorus and is the main influencer in the CKD-MBD process. In this study, we observed the correlation among serum FGF23 and calcium, phosphorus and parathyroid hormone, and the correlation between FGF23 levels and cardiac structural changes in MHD patients. Methods: We examined serum FGF23 concentrations in 107 cases of MHD patients using the ELISA method, recorded demographic information and biochemical data, and analyzed the correlation between serum FGF23 levels and blood calcium and blood phosphorus and PTH levels. All patients were evaluated by cardiac color ultrasound, and we finally analyzed the association between the FGF23 level and cardiac structural changes. Results: In 107 cases of MHD patients, serum FGF23 levels were linearly associated with serum calcium ( Conclusion: Serum FGF23 showed a positive correlation among blood calcium levels and PTH levels in hemodialysis patients, and FGF23 levels can affect the incidence of right atrial hypertrophy in MHD patients.

Identifiers

PMID37089720
PMCPMC10118877
OpenAlexW4362717677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.